Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

An intergroup phase III trial to evaluate the activity of Docetaxel, given either sequentially or in combination with doxorubicin, followed by cmf, in comparison to doxorubicin alone or in combination with cyclophosphamide, followed by cmf, in the adjuvant treatment of node-positive breast cancer patients
Docetaxel
RP56976_PR_315
NCT00174655
Breast Cancer
Phase 3
 
Datasets and document are available as per Sanofi Policy and criteria
November 2017

Powered by ideaPoint, Inc.